C-X-C motif chemokine ligand (CXCL) (CXCL)

The C-X-C motif chemokine ligand (CXCL) family is a group of small pro-inflammatory cytokines characterized by two conserved N-terminal cysteine residues separated by a single non-conserved amino acid (PubMed: 16785495). These proteins function primarily as chemoattractants, directing the migration of specific subsets of leukocytes, such as neutrophils and T-lymphocytes, to sites of inflammation and tissue damage (UniProt: P29274). Beyond immune cell recruitment, CXCL chemokines play pivotal roles in regulating angiogenesis, maintaining homeostatic stem cell niches, and facilitating wound repair (NCBI: NBK27125). In various diseases, particularly cancer, the over-expression of CXCL ligands like CXCL12 or CXCL8 promotes tumor cell survival, proliferation, and metastatic spread to distant organs (PubMed: 25103092). Therapeutic interventions targeting this family include monoclonal antibodies designed to neutralize the ligands and small molecule inhibitors that block their interaction with cognate G protein-coupled receptors (StatPearls: NBK537182). However, the high degree of redundancy within the chemokine system and their essential roles in host defense present significant challenges for drug development and clinical safety (PubMed: 12615900).

Other names

Alpha-chemokineCXC chemokineScyb familyIntercrine alpha familySmall-inducible cytokine B family

Ligand neutralization via monoclonal antibodies or aptamers, and inhibition of receptor binding within the CXCL-CXCR signaling axis using small molecule antagonists.